Items where authors include "Ciurtin, C"

Export as [feed] Atom [feed] RSS
Jump to: Article
Number of items: 7.

Article

Tucker, L, Allen, A, Chandler, D et al. (16 more authors) (2022) The 2022 British Society for Rheumatology guideline for the treatment of psoriatic arthritis with biologic and targeted synthetic DMARDs. Rheumatology. ISSN 1462-0324

Tucker, L, Allen, A, Chandler, D et al. (16 more authors) (2022) Executive summary: The 2022 British Society for Rheumatology guidelineā€‚for the treatment of psoriatic arthritis with biologic and targeted synthetic DMARDs. Rheumatology. keac260. ISSN 1462-0324

Mahmoud, K, Zayat, AS, Md Yusof, MY orcid.org/0000-0003-3131-9121 et al. (12 more authors) (2021) Ultrasound to identify systemic lupus erythematosus patients with musculoskeletal symptoms who respond best to therapy: the US Evaluation For mUsculoskeletal Lupus longitudinal multicentre study. Rheumatology, 60 (11). pp. 5194-5204. ISSN 1462-0324

Tillett, W, Allen, A, Tucker, L et al. (17 more authors) (2020) Treatment of psoriatic arthritis with biologic and targeted synthetic DMARDs: British Society for Rheumatology guideline scope. Rheumatology. keaa526. ISSN 1462-0324

Al-Laith, M, Jasenecova, M, Abraham, S et al. (27 more authors) (2019) Arthritis prevention in the pre-clinical phase of RA with abatacept (the APIPPRA study): a multi-centre, randomised, double-blind, parallel-group, placebo-controlled clinical trial protocol. Trials, 20 (1). 429. p. 429. ISSN 1745-6215

Tom, BDM, Symmons, D, Brockbank, S et al. (145 more authors) (2018) Novel methodology to discern predictors of remission and patterns of disease activity over time using rheumatoid arthritis clinical trials data. RMD OPEN, 4 (2). e000721. ISSN 2056-5933

Ciurtin, C, Majeed, Y, Naylor, J et al. (4 more authors) (2010) TRPM3 channel stimulated by pregnenolone sulphate in synovial fibroblasts and negatively coupled to hyaluronan. BMC Musculoskeletal Disorders, 11 (1). 111. ISSN 1471-2474

This list was generated on Sat Mar 23 11:36:56 2024 GMT.